The Utility of Serum Procalcitonin in Distinguishing Systemic Inflammatory Response Syndrome from Infection After Aneury

  • PDF / 731,724 Bytes
  • 7 Pages / 595.276 x 790.866 pts Page_size
  • 29 Downloads / 227 Views

DOWNLOAD

REPORT


ORIGINAL ARTICLE

The Utility of Serum Procalcitonin in Distinguishing Systemic Inflammatory Response Syndrome from Infection After Aneurysmal Subarachnoid Hemorrhage Emir Festic • Jason Siegel • Matthew Stritt William D. Freeman



Ó Springer Science+Business Media New York 2014

Abstract Background Systemic inflammatory response syndrome (SIRS) occurs frequently after aneurysmal subarachnoid hemorrhage (aSAH). It is a clinical challenge to distinguish between SIRS and incipient infection. Procalcitonin (PCT) has been studied among general critical care patients as a biomarker for infection. We hypothesized that PCT could be useful to distinguish SIRS from sepsis in aSAH patients. Methods Prospective, observational study conducted in the multidisciplinary intensive care unit at Mayo Clinic, Jacksonville, FL between August 2009 and September 2010. Main predictor was serum PCT obtained on admission and with subsequent episodes of SIRS. A level of 0.2 ng/mL or higher was considered as elevated PCT. Main outcome was clinical infection, which was subsequently subcategorized into major (systemic) and minor (localized) infections in the sensitivity analysis. Results Forty consecutive patients were enrolled. Majority (88 %) developed SIRS during the hospitalization. Infection developed in 16 (40 %) patients, with 6 patients meeting criteria for major infection. Overall, PCT was found to be highly specific for all infections and the subcategory of major infections (97 and 93 %, respectively) with related high negative predictive values. Odds

E. Festic (&)  M. Stritt Departments of Pulmonary and Critical Care, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA e-mail: [email protected] J. Siegel Department of Neurology, Mayo Clinic, Jacksonville, FL, USA W. D. Freeman Departments of Neurology, Neurosurgery and Critical Care, Mayo Clinic, Jacksonville, FL, USA

ratio for elevated PCT with clinical infections ranged from 25.2 (95 % CI 2.7–233) to 33.3 (95 % CI 4.3–261) for all and major infections, respectively. Related receiver operating characteristic curves for elevated PCT were 0.74 and 0.96 for all and major infections, respectively. Conclusions Procalcitonin of 0.2 ng/mL or greater was demonstrated to be very specific for sepsis among patients with aSAH. Further studies should validate this result and establish its clinical applicability. Keywords Procalcitonin  Subarachnoid hemorrhage  Systemic inflammatory response syndrome  Infection  Intensive care unit

Introduction Aneurysmal subarachnoid hemorrhage (aSAH) comprises about 8 % of all strokes with mortality reaching up to 40 % [1, 2]. Complications from aSAH could be broadly classified into neurological as well as general medical complications, the latter most commonly leading to development of fever and systemic inflammatory response syndrome (SIRS) [3]. SIRS after subarachnoid hemorrhage may occur in up to 83 % of patients [4], and is associated with the increased mortality [5]. The pathogenesis of SIRS after SAH remains poorly understood, but i